Lonza

Contact
lonza.com
+41613168111

Lonza Group Ltd

Muenchensteinerstrasse 38
4002 Basel
Switzerland
+41613168111
lonza.com
Contact
Profile Products News
Contact

About Lonza

Lonza continues to leverage its core strengths in innovation, technology, and regulatory expertise while capturing cross-divisional synergies in manufacturing, research, and sales. By clicking the Factsheet will find a detailed breakdown of our management committees, business divisions, group functions, key figures, and our sales by operating segments. In Facts & Figures you will learn more about Lonza as well as our extraordinary team, awards, and successes.

Read more about Lonza
Facts about Lonza
  • Focus : Manufacturer
  • Employees: 5,001-10,000
  • Industry : Pharma

Product portfolio of Lonza

Product portfolio

Show all

News about Lonza

Lonza

02-Apr-2024 | people

Lonza Appoints Wolfgang Wienand as New CEO

Albert M. Baehny will retire from Lonza following a transition period

Read news
Lonza

29-Jan-2024 | people

Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza

Longstanding Chairman of Lonza, Albert Baehny will not stand for re-election

Read news
Lonza

01-Jun-2023 | business & finance

Lonza to Acquire Synaffix

Strengthen Antibody-Drug Conjugates Offering

Read news
Lonza

20-Feb-2023 | manufacturing

Lonza Completes Expansion of Conjugation Facility in Visp

Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates

Read news
Lonza

25-Jan-2023 | business & finance

Lonza Delivers Strong 2022 Performance

Growth investment continues

Read news
Lonza

16-Dec-2021 | business & finance

Lonza and Agilent Announce Strategic Collaboration

The collaboration aims to develop and integrate current and new analytical technologies into patient-scale cell therapy manufacturing workflows

Read news
Lonza

01-Jul-2021 | business & finance

Lonza Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nansha, China

New investments will include three 1,000L GMP trains with an overall 12m3 of reactor volume

Read news
Lonza

03-Jun-2021 | business & finance

Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands

Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration will further extend the manufacture of the drug substance for ...

Read news
Show more news about Lonza

Here you will find Lonza Group Ltd